Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada 2026 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Real-World Evidence of SUL-DUR on Special Populations with CRAB InfectionRelease Date:Research Inflammation & Immunology China Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local LevelRelease Date:Quality Improvement Inflammation & Immunology China Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator TherapyRelease Date:Education Inflammation & Immunology USA Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold InfectionsRelease Date:Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patientsRelease Date:Quality Improvement Oncology Spain Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Title Grant Type Focus Area Country Application Due Date Enzalutamide in the Treatment of Prostate CancerRelease Date:Partner: National Comprehensive Cancer Network, AstellasResearch Oncology USA Education of Healthcare Professionals to Provide Appropriate Medical Care for Patients with Atopic DermatitisRelease Date:Education Inflammation & Immunology Japan Addressing Primary Immunodeficiencies within Minority/Underserved PopulationsRelease Date:Education Hospital USA Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S.Release Date:Research Rare Disease USA Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator Competitive Grant ProgramRelease Date:Quality Improvement Rare Disease USA Patient and Caregiver Awareness of Drug Resistant Infections (United States and Europe)Release Date:Education Hospital All Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic DiseasesRelease Date:Partner: The Japan College of RheumatologyQuality Improvement Inflammation & Immunology Japan A Quality Improvement Grant Request for Proposals Addressing Social Health Needs in Chronic and Preventative DiseaseQuality Improvement Internal Medicine USA Establishment of Support System for Healthy Life Extension of Patients with CV diseaseRelease Date:Quality Improvement Internal Medicine Japan Racial and Ethnic Disparities in the Menopause ExperienceRelease Date:Education Internal Medicine USA Immunotherapy in Urothelial CarcinomaRelease Date:Partner: Merck KGaA Darmstadt, Germany and EMD SeronoEducation Oncology All Managment of Metabolic Risks that Drive Liver Diseases and Increase Cardiovascular Risk in NASHRelease Date:Education Internal Medicine All NSCLC Biomarker TestingRelease Date:Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom Development of Talazoparib for Prostate CancerRelease Date:Partner: National Comprehensive Cancer NetworkResearch Oncology USA Approaches to Smoking Cessation CounselingRelease Date:Education Internal Medicine Australia, India, Japan, New Zealand, Singapore, Taiwan Burden of Community Acquired PneumoniaRelease Date:Research Vaccines USA Closing Knowledge Gaps in Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology USA Progress in Androgen Deprivation Therapy (ADT) in Advanced Prostate CancerEducation Oncology USA Efforts to Promote Team-based Care and Regional Medical Collaboration for Cancer PatientsRelease Date:Partner: Japan Society of Clinical OncologyQuality Improvement Oncology Japan ISID-Pfizer 2021 Grant ChallengeRelease Date:Partner: The International Society for Infectious Diseases (ISID)Quality Improvement Hospital All Hemophilia: Improve Knowledge Level of Gene TherapyRelease Date:Education Rare Disease Japan Data generation on the treatment of Metastatic Breast Cancer with CDK 4/6 inhibitorsRelease Date:Research Oncology Portugal China Medical Education in Breast Cancer Diagnosis and TreatmentRelease Date:Education Oncology China COVID-19 Epidemiology ResearchRelease Date:Research Vaccines Algeria, Egypt, Indonesia, Lebanon, Philippines, Thailand, Tunisia, Vietnam Understanding Healthcare disparities in IBD Patients in Underserved CommunitiesRelease Date:Quality Improvement Inflammation & Immunology Canada, USA Latin America Needs Assessment of Mental HealthRelease Date:Education Internal Medicine Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Partner: Mayo ClinicReview Process: Expert Review PanelQuality Improvement Rare Disease All Identifying and Diagnosing Juvenile Idiopathic Arthritis (JIA)Release Date:Education Inflammation & Immunology USA Antibiotic Stewardship in PediatricsRelease Date:Quality Improvement Hospital All China Educational Needs Assessment in Atopic DermatitisRelease Date:Education Inflammation & Immunology China China Medical Education in Atopic Dermatitis Awareness and TreatmentRelease Date:Education Inflammation & Immunology China Educational Activities to Improve Vaccination Rate beyond Clinical DepartmentsRelease Date:Education Vaccines Japan Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)Emerging Markets (Asia, Latin America, Africa, and Middle East)Release Date:Education Rare Disease All Improving the Knowledge Gap on Vaccine Safety AssessmentRelease Date:Education Vaccines Japan Promotion of the Appropriate Diagnosis and Treatment of Pediatric Neurogenic BladderRelease Date:Education Internal Medicine Japan Improve the Treatment Environment for Cancer Pain PatientsRelease Date:Education Internal Medicine Japan Promoting Pain Treatment in Osteoarthritis CareRelease Date:Education Internal Medicine Japan Appropriate Immunization among Patients with Immune-Mediated Inflammatory Diseases (IMIDs)Release Date:Quality Improvement Inflammation & Immunology All Developing Clinical Research and Publication Skills（Asia, AfME, Latin America and China）Release Date:Partner: British Medical Journal (BMJ)Education Internal Medicine All A Phased Approach to Understanding and Addressing Healthcare Disparities for People of ColorRelease Date:Partner: Conquer Cancer, The ASCO FoundationResearch Oncology USA PCF-Pfizer-Myovant Relugolix Challenge AwardsRelease Date:Partner: The Prostate Cancer Foundation and Myovant Sciences GmbHResearch Oncology USA BRAF-mutation Biomarker Testing in Colorectal Cancer and MelanomaRelease Date:Quality Improvement Oncology Canada Pfizer Innovation Challenge: Patient Preference Database BlueprintRelease Date:Research Support for the Professions All Management of Uterine Fibroids and EndometriosisEducation Internal Medicine USA COVID-19 Impact and SARS-CoV-2 Viral LifecycleRelease Date:Education Hospital USA Addressing Knowledge Gaps on Biosimilar Use in Inflammatory ConditionsRelease Date:Education Inflammation & Immunology USA Dermatology Research Fellowship in Skin of ColorFellowship Inflammation & Immunology USA NSCLC Therapy Management for Optimal Outcomes(Asia, Africa, Middle East, Latin America)Release Date:Quality Improvement Oncology All